ABCDEFGHIJKLMNOPQRSTUVWXYZ
| Name |
Category |
| ARQULE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits |
News |
| ARQULE INC Financials |
News |
| ArQule Inc. |
Fund |
| ArQule Management Discusses Q1 2013 Results - Earnings Call Transcript |
News |
| ArQule Regains ARQ 092 Rights |
News |
| ArQule Regains ARQ 092 Rights |
News |
| ArQule Regains Worldwide Rights to AKT Program |
News |
| ArQule Reports First Quarter 2013 Financial Results |
News |
| ArQule to Report First Quarter 2013 Financial Results on May 8, 2013 |
News |
| ArQule, Inc. to Present at Jefferies 2013 Global Healthcare Conference |
News |
| ArQule, Inc. to Present at Needham 12th Annual Healthcare Conference |
News |
| ArQule’s Novel AKT Pathway Inhibitor, ARQ 092, Demonstrates Safety, Target Inhibition in Phase 1 Trial |
News |
| Arran Watson |
Contact |
| Arran Res Mtg Fdg 2011-1 CMO |
Company |
| Array BioPharma Announces Pricing of Public Offering of $115 Million of Convertible Senior Notes |
News |
| Array BioPharma Announces Proposed Public Offering of Convertible Debt |
News |
| Array BioPharma Inc Conference Call to discuss its Collaboration with Oncothyreon to Develop and Commercialize anti-HER2 Compound ARRY-380 scheduled f |
News |
| ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
News |
| ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits |
News |
| Array BioPharma Inc. |
Fund |
| Array BioPharma To Present At The Jefferies 2013 Global Healthcare Conference |
News |
| Array BioPharma's CEO Presents at 2013 UBS Global Life Sciences Conference (Transcript) |
News |
| Array BioPharma's CEO Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript) |
News |
| Array/ONTY to Co-develop ARRY-380 |
News |
| ARRAYIT CORP Files SEC form 10-Q, Quarterly Report |
News |
Page 843 of 1100
Page 843 of 1100